Lv51
1440 积分 2021-09-05 加入
Indications and procedure for CAR T-cell infusion
48分钟前
已完结
PA-046 BCMA–Targeting Bispecific Antibody, as a Efficacy and Safety Bridging Therapy Before Anti-BCMA CAR-T Cell Therapy in Multiple Myeloma
1个月前
已完结
儿童/青少年癌症患者生育力保护的临床咨询及相关伦理问题
1个月前
已完结
儿童及青少年女性恶性肿瘤患者生育力保存专家共识（2025年）
1个月前
已完结
Neurological complications of CAR T cell therapy for cancers
2个月前
已完结
嵌合抗原受体T细胞治疗高级别脑胶质瘤的探索性临床研究专家共识(2026版)
2个月前
已完结
"Off-the-Shelf" Allogeneic CAR Cell Therapy-Neglected HvG Effect
3个月前
已完结
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
3个月前
已完结
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
4个月前
已完结
皖公网安备34019202002308
